News
Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...
Hosted on MSN2mon
Cognizant Set to Report Q4 Earnings: What's in Store for the Stock?Cognizant recently announced its collaboration with Gilead Sciences to expand their partnership. They will leverage machine learning, generative AI, and advanced technology solutions to enhance ...
Kumar cited Toyota, McDonald’s and Gilead Sciences as businesses already working with Cognizant’s AI capabilities. “As we think about AI-enabled enterprise landscapes, I’m very excited ...
The plaintiffs say they suffered unnecessary kidney and bone damage from taking one of Gilead's drugs, which could have swapped out an ingredient for a safer alternative. OAKLAND, Calif. (CN) — The ...
Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since he took the reins in 2019. O’Day received a compensation package of ...
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...
In this article, we are going to take a look at where Gilead Sciences Inc. (NASDAQ:GILD) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results